Although there is less evidence to support the role of keratin 16 in AD, recent research has shown that increased expression of KRT16 may be a marker for hyperproliferative keratinocytes in AD, and KRT16’s expression is significantly reduced in patients treated with dupilumab for AD [51,52]. The gene discussed is KRT16; the disease is Alzheimer disease.